{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,26]],"date-time":"2026-04-26T22:41:01Z","timestamp":1777243261598,"version":"3.51.4"},"publisher-location":"Singapore","reference-count":104,"publisher":"Springer Nature Singapore","isbn-type":[{"value":"9789819568710","type":"print"},{"value":"9789819568727","type":"electronic"}],"license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026]]},"DOI":"10.1007\/978-981-95-6872-7_2","type":"book-chapter","created":{"date-parts":[[2026,4,26]],"date-time":"2026-04-26T22:19:27Z","timestamp":1777241967000},"page":"15-29","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Blood-Based Metabolomic Biomarkers and Personality Traits in Major Depressive Disorder: Toward an Integrated Framework for Precision Psychiatry"],"prefix":"10.1007","author":[{"given":"Daiki","family":"Setoyama","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshio","family":"Matsushima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takahiro A.","family":"Kato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,4,1]]},"reference":[{"key":"2_CR1","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1038\/npp.2009.160","volume":"35","author":"PJ Allen","year":"2010","unstructured":"Allen PJ, D\u2019Anci KE, Kanarek RB, Renshaw PF (2010) Chronic creatine supplementation alters depression-like behavior in rodents in a sex-dependent manner. Neuropsychopharmacology 35:534\u2013546","journal-title":"Neuropsychopharmacology"},{"key":"2_CR2","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1001\/jamapsychiatry.2023.0685","volume":"80","author":"N Amin","year":"2023","unstructured":"Amin N, Liu J, Bonnechere B, Mahmoudiandehkordi S, Arnold M, Batra R, Chiou YJ, Fernandes M, Ikram MA, Kraaij R et al (2023) Interplay of metabolome and gut microbiome in individuals with major depressive disorder vs control individuals. JAMA Psychiatry 80:597\u2013609","journal-title":"JAMA Psychiatry"},{"key":"2_CR3","doi-asserted-by":"publisher","first-page":"64","DOI":"10.3390\/bs7040064","volume":"7","author":"S Assari","year":"2017","unstructured":"Assari S (2017) Neuroticism predicts subsequent risk of major depression for whites but not blacks. Behav Sci 7:64","journal-title":"Behav Sci"},{"key":"2_CR4","first-page":"347","volume":"10","author":"RM Bagby","year":"2008","unstructured":"Bagby RM, Quilty LC, Ryder AG, Pilkonis PA (2008) Personality and depression. Dialogues Clin Neurosci 10:347\u2013361","journal-title":"Dialogues Clin Neurosci"},{"key":"2_CR5","doi-asserted-by":"crossref","unstructured":"Bhattacharyya S, Dunlop BW, Mahmoudiandehkordi S, Ahmed AT, Louie G, Frye MA, Weinshilboum RM, Krishnan RR, Rush AJ, Mayberg HS et al (2019) Pilot study of metabolomic clusters as state markers of major depression and outcomes to CBT treatment. Front Neurosci [Internet] 13. Available from: https:\/\/www.frontiersin.org\/article\/10.3389\/fnins.2019.00926\/full","DOI":"10.3389\/fnins.2019.00926"},{"key":"2_CR6","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1111\/j.1600-0447.2005.00702.x","volume":"113","author":"J Brezo","year":"2006","unstructured":"Brezo J, Paris J, Turecki G (2006) Personality traits as correlates of suicidal ideation, suicide attempts, and suicide completions: a systematic review. Acta Psychiatr Scand 113:180\u2013206","journal-title":"Acta Psychiatr Scand"},{"key":"2_CR7","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1192\/bjp.bp.111.097519","volume":"200","author":"R Bruffaerts","year":"2012","unstructured":"Bruffaerts R, Vilagut G, Demyttenaere K, Alonso J, AlHamzawi A, Andrade LH, Benjet C, Bromet E, Bunting B, de Girolamo G et al (2012) Role of common mental and physical disorders in partial disability around the world. Br J Psychiatry 200:454\u2013461","journal-title":"Br J Psychiatry"},{"key":"2_CR8","first-page":"223","volume":"3","author":"D Bzdok","year":"2018","unstructured":"Bzdok D, Meyer-Lindenberg A (2018) Machine learning for precision psychiatry: opportunities and challenges. Biol Psychiatry: Cognit Neurosci Neuroimaging 3:223\u2013230","journal-title":"Biol Psychiatry: Cognit Neurosci Neuroimaging"},{"key":"2_CR9","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1080\/19585969.2025.2513697","volume":"27","author":"Z Cao","year":"2025","unstructured":"Cao Z, Setoyama D, Natsumi Daudelin M, Matsushima T, Yada Y, Watabe M, Hikida T, A Kato T, Naoki H (2025) Leveraging machine learning to uncover the hidden links between trusting behavior and biological markers. Dialogues Clin Neurosci 27:201\u2013215","journal-title":"Dialogues Clin Neurosci"},{"key":"2_CR10","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/j.jad.2010.07.002","volume":"128","author":"JD Carter","year":"2011","unstructured":"Carter JD, Luty SE, McKenzie JM, Mulder RT, Frampton CM, Joyce PR (2011) Patient predictors of response to cognitive behaviour therapy and interpersonal psychotherapy in a randomised clinical trial for depression. J Affect Disord 128:252\u2013261","journal-title":"J Affect Disord"},{"key":"2_CR11","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/S2215-0366(15)00471-X","volume":"3","author":"AM Chekroud","year":"2016","unstructured":"Chekroud AM, Zotti RJ, Shehzad Z, Gueorguieva R, Johnson MK, Trivedi MH, Cannon TD, Krystal JH, Corlett PR (2016) Cross-trial prediction of treatment outcome in depression: a machine learning approach. Lancet Psychiatry 3:243\u2013250","journal-title":"Lancet Psychiatry"},{"key":"2_CR12","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1001\/archpsyc.1993.01820240059008","volume":"50","author":"CR Cloninger","year":"1993","unstructured":"Cloninger CR, Svrakic DM, Przybeck TR (1993) A psychobiological model of temperament and character. Arch Gen Psychiatry 50:975\u2013990","journal-title":"Arch Gen Psychiatry"},{"key":"2_CR13","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1034\/j.1399-0004.2000.580508.x","volume":"58","author":"D Comings","year":"2000","unstructured":"Comings D, Gade-Andavolu R, Gonzalez N, Wu S, Muhleman D, Blake H, Mann M, Dietz G, Saucier G, MacMurray J (2000) A multivariate analysis of 59 candidate genes in personality traits: the temperament and character inventory. Clin Genet 58:375\u2013385","journal-title":"Clin Genet"},{"key":"2_CR14","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1186\/1741-7015-11-126","volume":"11","author":"BN Cuthbert","year":"2013","unstructured":"Cuthbert BN, Insel TR (2013) Toward the future of psychiatric diagnosis: the seven pillars of RDoC. BMC Med 11:126","journal-title":"BMC Med"},{"key":"2_CR15","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1038\/nm.4246","volume":"23","author":"AT Drysdale","year":"2017","unstructured":"Drysdale AT, Grosenick L, Downar J, Dunlop K, Mansouri F, Meng Y, Fetcho RN, Zebley B, Oathes DJ, Etkin A et al (2017) Resting-state connectivity biomarkers define neurophysiological subtypes of depression. Nat Med 23:28\u201338","journal-title":"Nat Med"},{"key":"2_CR16","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-73918-z","volume":"10","author":"H Erabi","year":"2020","unstructured":"Erabi H, Okada G, Shibasaki C, Setoyama D, Kang D, Takamura M, Yoshino A, Fuchikami M, Kurata A, Kato TA et al (2020) Kynurenic acid is a potential overlapped biomarker between diagnosis and treatment response for depression from metabolome analysis. Sci Rep 10:16822","journal-title":"Sci Rep"},{"key":"2_CR17","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0091936","volume":"9","author":"AJ Ferrari","year":"2014","unstructured":"Ferrari AJ, Norman RE, Freedman G, Baxter AJ, Pirkis JE, Harris MG, Page A, Carnahan E, Degenhardt L, Vos T et al (2014) The burden attributable to mental and substance use disorders as risk factors for suicide: findings from the Global Burden of Disease Study 2010. Baune BT, editor. PLoS One 9:e91936","journal-title":"PLoS One"},{"key":"2_CR18","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1038\/s41380-022-01806-1","volume":"28","author":"GR Fries","year":"2023","unstructured":"Fries GR, Saldana VA, Finnstein J, Rein T (2023) Molecular pathways of major depressive disorder converge on the synapse. Mol Psychiatry 28:284\u2013297","journal-title":"Mol Psychiatry"},{"key":"2_CR19","doi-asserted-by":"crossref","unstructured":"Fujimoto K, Hosoi M, Katsuki R, Matsushima T, Matsuo K, Nakao T, Sudo N, Kato TA (2022) Psychological traits of patients with depression comorbid with chronic pain: are complaint and competitive tendency related to pain? Front Psychiatry [Internet] 13. Available from: https:\/\/www.frontiersin.org\/articles\/10.3389\/fpsyt.2022.825422\/full","DOI":"10.3389\/fpsyt.2022.825422"},{"key":"2_CR20","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1002\/j.2051-5545.2011.tb00061.x","volume":"10","author":"D Goldberg","year":"2011","unstructured":"Goldberg D (2011) The heterogeneity of \u201cmajor depression.\u201d. World Psychiatry 10:226\u2013228","journal-title":"World Psychiatry"},{"key":"2_CR21","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1001\/jamapsychiatry.2014.2206","volume":"72","author":"M Goodkind","year":"2015","unstructured":"Goodkind M, Eickhoff SB, Oathes DJ, Jiang Y, Chang A, Jones-Hagata LB, Ortega BN, Zaiko YV, Roach EL, Korgaonkar MS et al (2015) Identification of a common neurobiological substrate for mental illness. JAMA Psychiatry 72:305","journal-title":"JAMA Psychiatry"},{"key":"2_CR22","doi-asserted-by":"crossref","unstructured":"Grant CW, Wilton AR, Kaddurah-Daouk R, Skime M, Biernacka J, Mayes T, Carmody T, Wang L, Lazaridis K, Weinshilboum R et al (2022) Network science approach elucidates integrative genomic-metabolomic signature of antidepressant response and lifetime history of attempted suicide in adults with major depressive disorder. Front Pharmacol [Internet] 13. Available from: https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2022.984383\/full","DOI":"10.3389\/fphar.2022.984383"},{"key":"2_CR23","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1002\/da.22376","volume":"32","author":"C Hakulinen","year":"2015","unstructured":"Hakulinen C, Elovainio M, Pulkki-R\u00e5back L, Virtanen M, Kivim\u00e4ki M, Jokela M (2015) Personality and depressive symptoms: individual participant META-analysis of 10 cohort studies. Depress Anxiety 32:461\u2013470","journal-title":"Depress Anxiety"},{"key":"2_CR24","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1186\/s13059-017-1215-1","volume":"18","author":"Y Hasin","year":"2017","unstructured":"Hasin Y, Seldin M, Lusis A (2017) Multi-omics approaches to disease. Genome Biol 18:83","journal-title":"Genome Biol"},{"key":"2_CR25","doi-asserted-by":"publisher","first-page":"1765","DOI":"10.1038\/sj.npp.1300506","volume":"29","author":"G Hasler","year":"2004","unstructured":"Hasler G, Drevets WC, Manji HK, Charney DS (2004) Discovering endophenotypes for major depression. Neuropsychopharmacology 29:1765\u20131781","journal-title":"Neuropsychopharmacology"},{"key":"2_CR26","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1016\/S0140-6736(21)02141-3","volume":"399","author":"H Herrman","year":"2022","unstructured":"Herrman H, Patel V, Kieling C, Berk M, Buchweitz C, Cuijpers P, Furukawa TA, Kessler RC, Kohrt BA, Maj M et al (2022) Time for united action on depression: a Lancet\u2013World Psychiatric Association Commission. Lancet 399:957\u20131022","journal-title":"Lancet"},{"issue":"Suppl 6","key":"2_CR27","first-page":"4","volume":"61","author":"RM Hirschfeld","year":"2000","unstructured":"Hirschfeld RM (2000) History and evolution of the monoamine hypothesis of depression. J Clin Psychiatry 61(Suppl 6):4\u20136","journal-title":"J Clin Psychiatry"},{"key":"2_CR28","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.0030327","volume":"3","author":"E Holmes","year":"2006","unstructured":"Holmes E, Tsang TM, Huang JT-J, Leweke FM, Koethe D, Gerth CW, Nolden BM, Gross S, Schreiber D, Nicholson JK et al (2006) Metabolic profiling of CSF: evidence that early intervention may impact on disease progression and outcome in schizophrenia. PLoS Med 3:e327","journal-title":"PLoS Med"},{"key":"2_CR29","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1016\/j.cell.2008.08.026","volume":"134","author":"E Holmes","year":"2008","unstructured":"Holmes E, Wilson ID, Nicholson JK (2008) Metabolic phenotyping in health and disease. Cell 134:714\u2013717","journal-title":"Cell"},{"key":"2_CR30","doi-asserted-by":"publisher","first-page":"2455","DOI":"10.1017\/S0033291716001367","volume":"46","author":"R Iniesta","year":"2016","unstructured":"Iniesta R, Stahl D, McGuffin P (2016) Machine learning, statistical learning and the future of biological research in psychiatry. Psychol Med 46:2455\u20132465","journal-title":"Psychol Med"},{"key":"2_CR31","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1001\/jama.2017.11295","volume":"318","author":"TR Insel","year":"2017","unstructured":"Insel TR (2017) Digital phenotyping. JAMA 318:1215","journal-title":"JAMA"},{"key":"2_CR32","doi-asserted-by":"publisher","first-page":"357","DOI":"10.32598\/ijvm.19.2.1005466","volume":"19","author":"JG Jalal","year":"2025","unstructured":"Jalal JG, Hassanpour S (2025) Effects of betaine on ameliorating depression in gonadectomized male rats. Iran J Vet Med 19:357\u2013365","journal-title":"Iran J Vet Med"},{"key":"2_CR33","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1038\/nrm.2016.25","volume":"17","author":"CH Johnson","year":"2016","unstructured":"Johnson CH, Ivanisevic J, Siuzdak G (2016) Metabolomics: beyond biomarkers and towards mechanisms. Nat Rev Mol Cell Biol 17:451\u2013459","journal-title":"Nat Rev Mol Cell Biol"},{"key":"2_CR34","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1192\/bjp.bp.106.024737","volume":"190","author":"PR Joyce","year":"2007","unstructured":"Joyce PR, McKenzie JM, Carter JD, Rae AM, Luty SE, Frampton CMA, Mulder RT (2007) Temperament, character and personality disorders as predictors of response to interpersonal psychotherapy and cognitive-behavioural therapy for depression. Br J Psychiatry 190:503\u2013508","journal-title":"Br J Psychiatry"},{"key":"2_CR35","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/j.eurpsy.2005.09.003","volume":"21","author":"P Jylh\u00e4","year":"2006","unstructured":"Jylh\u00e4 P, Isomets\u00e4 E (2006) Temperament, character and symptoms of anxiety and depression in the general population. Eur Psychiatry 21:389\u2013395","journal-title":"Eur Psychiatry"},{"key":"2_CR36","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1111\/pcn.13373","volume":"76","author":"T Kamishikiryo","year":"2022","unstructured":"Kamishikiryo T, Okada G, Itai E, Masuda Y, Yokoyama S, Takamura M, Fuchikami M, Yoshino A, Mawatari K, Numata S et al (2022) Left <scp>DLPFC<\/scp> activity is associated with plasma kynurenine levels and can predict treatment response to escitalopram in major depressive disorder. Psychiatry Clin Neurosci 76:367\u2013376","journal-title":"Psychiatry Clin Neurosci"},{"key":"2_CR37","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1373\/clinchem.2013.211979","volume":"60","author":"B Kamlage","year":"2014","unstructured":"Kamlage B, Maldonado SG, Bethan B, Peter E, Schmitz O, Liebenberg V, Schatz P (2014) Quality markers addressing preanalytical variations of blood and plasma processing identified by broad and targeted metabolite profiling. Clin Chem 60:399\u2013412","journal-title":"Clin Chem"},{"key":"2_CR38","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1176\/appi.ajp.2017.17010059","volume":"174","author":"TA Kato","year":"2017","unstructured":"Kato TA, Kanba S (2017a) Modern-type depression as an \u201cadjustment\u201d disorder in Japan: the intersection of collectivistic society encountering an individualistic performance-based system. Am J Psychiatry 174:1051\u20131053","journal-title":"Am J Psychiatry"},{"key":"2_CR39","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1176\/appi.ajp.2017.17050592r","volume":"174","author":"TA Kato","year":"2017","unstructured":"Kato TA, Kanba S (2017b) Modern-type depression as an illness of civilization: a review. Am J Psychiatry 174:1123\u20131130","journal-title":"Am J Psychiatry"},{"key":"2_CR40","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1111\/pcn.12842","volume":"73","author":"TA Kato","year":"2019","unstructured":"Kato TA, Katsuki R, Kubo H, Shimokawa N, Sato-Kasai M, Hayakawa K, Kuwano N, Umene-Nakano W, Tateno M, Setoyama D et al (2019) Development and validation of the 22-item Tarumi\u2019s modern-type depression trait scale: avoidance of social roles, complaint, and low self-esteem (TACS-22). Psychiatry Clin Neurosci 73:448\u2013457","journal-title":"Psychiatry Clin Neurosci"},{"key":"2_CR41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1539\/joh.15-0001-ER","volume":"58","author":"N Kawakami","year":"2016","unstructured":"Kawakami N, Tsutsumi A (2016) The Stress Check Program: a new national policy for monitoring and screening psychosocial stress in the workplace in Japan. J Occup Health 58:1\u20136","journal-title":"J Occup Health"},{"key":"2_CR42","doi-asserted-by":"crossref","unstructured":"Kehrer C (2008) Altered excitatory-inhibitory balance in the NMDA-hypofunction model of schizophrenia. Front Mol Neurosci [Internet] 1. Available from: http:\/\/journal.frontiersin.org\/article\/10.3389\/neuro.02.006.2008\/abstract","DOI":"10.3389\/neuro.02.006.2008"},{"key":"2_CR43","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1192\/bjp.186.3.190","volume":"186","author":"AA Khan","year":"2005","unstructured":"Khan AA, Jacobson KC, Gardner CO, Prescott CA, Kendler KS (2005) Personality and comorbidity of common psychiatric disorders. Br J Psychiatry 186:190\u2013196","journal-title":"Br J Psychiatry"},{"key":"2_CR44","doi-asserted-by":"crossref","unstructured":"Kiemes A, Davies C, Kempton MJ, Lukow PB, Bennallick C, Stone JM, Modinos G (2021) GABA, glutamate and neural activity: a systematic review with meta-analysis of multimodal 1H-MRS-fMRI studies. Front Psychiatry 12","DOI":"10.3389\/fpsyt.2021.644315"},{"key":"2_CR45","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1146\/annurev-clinpsy-032210-104540","volume":"7","author":"DN Klein","year":"2011","unstructured":"Klein DN, Kotov R, Bufferd SJ (2011) Personality and depression: explanatory models and review of the evidence. Annu Rev Clin Psychol 7:269\u2013295","journal-title":"Annu Rev Clin Psychol"},{"key":"2_CR46","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/tp.2014.19","volume":"4","author":"S Koike","year":"2014","unstructured":"Koike S, Bundo M, Iwamoto K, Suga M, Kuwabara H, Ohashi Y, Shinoda K, Takano Y, Iwashiro N, Satomura Y et al (2014) A snapshot of plasma metabolites in first-episode schizophrenia: a capillary electrophoresis time-of-flight mass spectrometry study. Transl Psychiatry 4:1\u20138","journal-title":"Transl Psychiatry"},{"key":"2_CR47","doi-asserted-by":"crossref","unstructured":"Komori T, Makinodan M, Kishimoto T (2019) Social status and modern-type depression: a review. Brain Behav [Internet] 9. Available from: https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/brb3.1464","DOI":"10.1002\/brb3.1464"},{"key":"2_CR48","doi-asserted-by":"crossref","unstructured":"Konjevod M, S\u00e1iz J, Bordoy L, Strac DS, Taha AY, Lanceros-M\u00e9ndez S, Alonso RM (2025) Validated metabolomic biomarkers in psychiatric disorders: a narrative review. Mol Med 31","DOI":"10.1186\/s10020-025-01258-7"},{"key":"2_CR49","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1038\/nature07455","volume":"455","author":"V Krishnan","year":"2008","unstructured":"Krishnan V, Nestler EJ (2008) The molecular neurobiology of depression. Nature 455:894\u2013902","journal-title":"Nature"},{"key":"2_CR50","doi-asserted-by":"publisher","first-page":"S71","DOI":"10.1038\/sj.mp.4001021","volume":"7","author":"JH Krystal","year":"2002","unstructured":"Krystal JH, Sanacora G, Blumberg H, Anand A, Charney DS, Marek G, Epperson CN, Goddard A, Mason GF (2002) Glutamate and GABA systems as targets for novel antidepressant and mood-stabilizing treatments. Mol Psychiatry 7:S71\u2013S80","journal-title":"Mol Psychiatry"},{"key":"2_CR51","doi-asserted-by":"crossref","unstructured":"Kubo H, Setoyama D, Watabe M, Ohgidani M, Hayakawa K, Kuwano N, Sato-Kasai M, Katsuki R, Kanba S, Kang D et al (2021) Plasma acetylcholine and nicotinic acid are correlated with focused preference for photographed females in depressed males: an economic game study. Sci Rep 11","DOI":"10.1038\/s41598-020-75115-4"},{"key":"2_CR52","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1017\/S1092852900010403","volume":"10","author":"A Kugaya","year":"2005","unstructured":"Kugaya A, Sanacora G (2005) Beyond monoamines: glutamatergic function in mood disorders. CNS Spectr 10:808\u2013819","journal-title":"CNS Spectr"},{"key":"2_CR53","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1111\/pcn.12299","volume":"69","author":"H Kunugi","year":"2015","unstructured":"Kunugi H, Hori H, Ogawa S (2015) Biochemical markers subtyping major depressive disorder. Psychiatry Clin Neurosci 69:597\u2013608","journal-title":"Psychiatry Clin Neurosci"},{"key":"2_CR54","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/1756-6606-3-8","volume":"3","author":"S Lee","year":"2010","unstructured":"Lee S, Jeong J, Kwak Y, Park SK (2010) Depression research: where are we now? Mol Brain 3:8","journal-title":"Mol Brain"},{"key":"2_CR55","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s12929-016-0314-8","volume":"24","author":"M-Y Lee","year":"2017","unstructured":"Lee M-Y, Lin Y-R, Tu Y-S, Tseng YJ, Chan M-H, Chen H-H (2017) Effects of sarcosine and N, N-dimethylglycine on NMDA receptor-mediated excitatory field potentials. J Biomed Sci 24:18","journal-title":"J Biomed Sci"},{"key":"2_CR56","doi-asserted-by":"publisher","DOI":"10.1016\/j.brainresbull.2023.110863","volume":"206","author":"Y Liang","year":"2024","unstructured":"Liang Y, Chen L, Huang Y, Xie L, Liu X, Zhou W, Cao W, Chen Z, Zhong X (2024) Betaine eliminates CFA-induced depressive-like behaviour in mice may be through inhibition of microglia and astrocyte activation and polarization. Brain Res Bull 206:110863","journal-title":"Brain Res Bull"},{"key":"2_CR57","first-page":"1","volume":"16","author":"F Liu","year":"2025","unstructured":"Liu F, Zhong X, Wang C (2025) Lower creatinine levels are associated with an increased risk of depression: evidence from the China Health and Retirement Longitudinal Study. Front Psych 16:1\u201310","journal-title":"Front Psych"},{"key":"2_CR58","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1007\/s10862-005-5384-y","volume":"27","author":"JM Malouff","year":"2005","unstructured":"Malouff JM, Thorsteinsson EB, Schutte NS (2005) The relationship between the five-factor model of personality and symptoms of clinical disorders: a meta-analysis. J Psychopathol Behav Assess 27:101\u2013114","journal-title":"J Psychopathol Behav Assess"},{"key":"2_CR59","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1080\/19585969.2025.2452842","volume":"27","author":"K Matsuo","year":"2025","unstructured":"Matsuo K, Watanabe M, Inamine S, Matsushima T, Kyuragi S, Maeda Y, Katsuki R, Ohgidani M, Yamasaki R, Isobe N et al (2025) The flow cytometric analysis of depression focusing on modern-type depression and hikikomori: exploring the link between subtypes of depression and immunological imbalances. Dialogues Clin Neurosci 27:13\u201325","journal-title":"Dialogues Clin Neurosci"},{"key":"2_CR60","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s13034-016-0140-5","volume":"11","author":"EC Merten","year":"2017","unstructured":"Merten EC, Cwik JC, Margraf J, Schneider S (2017) Overdiagnosis of mental disorders in children and adolescents (in developed countries). Child Adolesc Psychiatry Ment Health 11:5","journal-title":"Child Adolesc Psychiatry Ment Health"},{"key":"2_CR61","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1038\/nrn1993","volume":"7","author":"A Meyer-Lindenberg","year":"2006","unstructured":"Meyer-Lindenberg A, Weinberger DR (2006) Intermediate phenotypes and genetic mechanisms of psychiatric disorders. Nat Rev Neurosci 7:818\u2013827","journal-title":"Nat Rev Neurosci"},{"key":"2_CR62","doi-asserted-by":"publisher","first-page":"402","DOI":"10.3390\/biom11030402","volume":"11","author":"J Mierziak","year":"2021","unstructured":"Mierziak J, Burgberger M, Wojtasik W (2021) 3-Hydroxybutyrate as a metabolite and a signal molecule regulating processes of living organisms. Biomolecules 11:402","journal-title":"Biomolecules"},{"key":"2_CR63","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.3390\/brainsci11101298","volume":"11","author":"J Mikulska","year":"2021","unstructured":"Mikulska J, Juszczyk G, Gawro\u0144ska-Grzywacz M, Herbet M (2021) HPA axis in the pathomechanism of depression and schizophrenia: new therapeutic strategies based on its participation. Brain Sci 11:1298","journal-title":"Brain Sci"},{"key":"2_CR64","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1016\/j.pnpbp.2006.03.036","volume":"30","author":"H Mitani","year":"2006","unstructured":"Mitani H, Shirayama Y, Yamada T, Maeda K, Ashby CR, Kawahara R (2006) Correlation between plasma levels of glutamate, alanine and serine with severity of depression. Prog Neuro-Psychopharmacol Biol Psychiatry 30:1155\u20131158","journal-title":"Prog Neuro-Psychopharmacol Biol Psychiatry"},{"key":"2_CR65","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1016\/j.jad.2019.11.061","volume":"262","author":"SD Mitro","year":"2020","unstructured":"Mitro SD, Larrabure-Torrealva GT, Sanchez SE, Molsberry SA, Williams MA, Clish C, Gelaye B (2020) Metabolomic markers of antepartum depression and suicidal ideation. J Affect Disord 262:422\u2013428","journal-title":"J Affect Disord"},{"key":"2_CR66","doi-asserted-by":"publisher","first-page":"4926","DOI":"10.1073\/pnas.97.9.4926","volume":"97","author":"J-P Mothet","year":"2000","unstructured":"Mothet J-P, Parent AT, Wolosker H, Brady RO, Linden DJ, Ferris CD, Rogawski MA, Snyder SH (2000) D-Serine is an endogenous ligand for the glycine site of the N-methyl-D-aspartate receptor. Proc Natl Acad Sci 97:4926\u20134931","journal-title":"Proc Natl Acad Sci"},{"key":"2_CR67","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1080\/004982599238047","volume":"29","author":"JK Nicholson","year":"1999","unstructured":"Nicholson JK, Lindon JC, Holmes E (1999) \u201cMetabonomics\u201d: understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic data. Xenobiotica 29:1181\u20131189","journal-title":"Xenobiotica"},{"key":"2_CR68","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.neubiorev.2018.03.023","volume":"90","author":"K Ogyu","year":"2018","unstructured":"Ogyu K, Kubo K, Noda Y, Iwata Y, Tsugawa S, Omura Y, Wada M, Tarumi R, Plitman E, Moriguchi S et al (2018) Kynurenine pathway in depression: a systematic review and meta-analysis. Neurosci Biobehav Rev 90:16\u201325","journal-title":"Neurosci Biobehav Rev"},{"key":"2_CR69","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1016\/j.bbi.2020.02.010","volume":"87","author":"EF Osimo","year":"2020","unstructured":"Osimo EF, Pillinger T, Rodriguez IM, Khandaker GM, Pariante CM, Howes OD (2020) Inflammatory markers in depression: a meta-analysis of mean differences and variability in 5,166 patients and 5,083 controls. Brain Behav Immun 87:901\u2013909","journal-title":"Brain Behav Immun"},{"key":"2_CR70","doi-asserted-by":"publisher","first-page":"16065","DOI":"10.1038\/nrdp.2016.65","volume":"2","author":"C Otte","year":"2016","unstructured":"Otte C, Gold SM, Penninx BW, Pariante CM, Etkin A, Fava M, Mohr DC, Schatzberg AF (2016) Major depressive disorder. Nat Rev Dis Prim 2:16065","journal-title":"Nat Rev Dis Prim"},{"key":"2_CR71","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1016\/j.jad.2023.07.078","volume":"339","author":"W Ou","year":"2023","unstructured":"Ou W, Chen Y, Ju Y, Ma M, Qin Y, Bi Y, Liao M, Liu B, Liu J, Zhang Y et al (2023) The kynurenine pathway in major depressive disorder under different disease states: a systematic review and meta-analysis. J Affect Disord 339:624\u2013632","journal-title":"J Affect Disord"},{"key":"2_CR72","doi-asserted-by":"crossref","unstructured":"Parziale A, Mascalzoni D (2022) Digital biomarkers in psychiatric research: data protection qualifications in a complex ecosystem. Front Psychiatry [Internet] 13. Available from: https:\/\/www.frontiersin.org\/articles\/10.3389\/fpsyt.2022.873392\/full","DOI":"10.3389\/fpsyt.2022.873392"},{"key":"2_CR73","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1038\/nrm3314","volume":"13","author":"GJ Patti","year":"2012","unstructured":"Patti GJ, Yanes O, Siuzdak G (2012) Innovation: metabolomics: the apogee of the omics trilogy. Nat Rev Mol Cell Biol 13:263\u2013269","journal-title":"Nat Rev Mol Cell Biol"},{"key":"2_CR74","first-page":"363","volume":"28","author":"A Pelissolo","year":"2002","unstructured":"Pelissolo A, Corruble E (2002) Personality factors in depressive disorders: contribution of the psychobiologic model developed by Cloninger. L\u2019Encephale 28:363\u2013373","journal-title":"L\u2019Encephale"},{"key":"2_CR75","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1080\/10615806.2020.1845431","volume":"34","author":"EJ Prince","year":"2021","unstructured":"Prince EJ, Siegel DJ, Carroll CP, Sher KJ, Bienvenu OJ (2021) A longitudinal study of personality traits, anxiety, and depressive disorders in young adults. Anxiety Stress Coping 34:299\u2013307","journal-title":"Anxiety Stress Coping"},{"key":"2_CR76","doi-asserted-by":"publisher","first-page":"4265","DOI":"10.1038\/s41380-020-0645-4","volume":"26","author":"J Pu","year":"2021","unstructured":"Pu J, Liu Y, Zhang H, Tian L, Gui S, Yu Y, Chen X, Chen Y, Yang L, Ran Y et al (2021) An integrated meta-analysis of peripheral blood metabolites and biological functions in major depressive disorder. Mol Psychiatry 26:4265\u20134276","journal-title":"Mol Psychiatry"},{"key":"2_CR77","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.jad.2020.03.095","volume":"272","author":"Y Qu","year":"2020","unstructured":"Qu Y, Zhang K, Pu Y, Chang L, Wang S, Tan Y, Wang X, Zhang J, Ohnishi T, Yoshikawa T et al (2020) Betaine supplementation is associated with the resilience in mice after chronic social defeat stress: a role of brain\u2013gut\u2013microbiota axis. J Affect Disord 272:66\u201376","journal-title":"J Affect Disord"},{"key":"2_CR78","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.jad.2007.10.022","volume":"108","author":"LC Quilty","year":"2008","unstructured":"Quilty LC, De Fruyt F, Rolland J-P, Kennedy SH, Rouillon PF, Bagby RM (2008) Dimensional personality traits and treatment outcome in patients with major depressive disorder. J Affect Disord 108:241\u2013250","journal-title":"J Affect Disord"},{"key":"2_CR79","doi-asserted-by":"crossref","unstructured":"Rashidi-Ranjbar N, Miranda D, Butters MA, Mulsant BH, Voineskos AN (2020) Evidence for structural and functional alterations of frontal-executive and corticolimbic circuits in late-life depression and relationship to mild cognitive impairment and dementia: a systematic review. Front Neurosci [Internet] 14. Available from: https:\/\/www.frontiersin.org\/article\/10.3389\/fnins.2020.00253\/full","DOI":"10.3389\/fnins.2020.00253"},{"key":"2_CR80","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1176\/appi.ajp.2012.12070999","volume":"170","author":"DA Regier","year":"2013","unstructured":"Regier DA, Narrow WE, Clarke DE, Kraemer HC, Kuramoto SJ, Kuhl EA, Kupfer DJ (2013) DSM-5 field trials in the United States and Canada, part II: test-retest reliability of selected categorical diagnoses. Am J Psychiatry 170:59\u201370","journal-title":"Am J Psychiatry"},{"key":"2_CR81","doi-asserted-by":"publisher","first-page":"1785","DOI":"10.2147\/IJGM.S300517","volume":"14","author":"N Saito","year":"2021","unstructured":"Saito N, Itoga M, Minakawa S, Kayaba H (2021) Serum 3-hydroxybutyrate in patients with psychogenic somatoform symptoms may be a predictor of the effectiveness of sertraline and venlafaxine. Int J Gen Med 14:1785\u20131795","journal-title":"Int J Gen Med"},{"key":"2_CR82","doi-asserted-by":"crossref","unstructured":"Sakurai H, Setoyama D, Kato TA, Tachimori H, Murano M, Matsumoto Y, Tada T, Imamura Y, Seki H, Tsuboi T, Uchida H (2025) Acute and long-term effects of repeated ketamine infusions in treatment-resistant depression and associated metabolite changes. Psychiatry Clin Neurosci, in press","DOI":"10.1111\/pcn.13870"},{"key":"2_CR83","doi-asserted-by":"publisher","DOI":"10.3390\/biom15040502","volume":"15","author":"A S\u0103lcudean","year":"2025","unstructured":"S\u0103lcudean A, Bodo C-R, Popovici R-A, Cozma M-M, P\u0103curar M, Cr\u0103ciun R-E, Crisan A-I, Enatescu V-R, Marinescu I, Cimpian D-M et al (2025) Neuroinflammation\u2014a crucial factor in the pathophysiology of depression\u2014a comprehensive review. Biomolecules 15:502","journal-title":"Biomolecules"},{"key":"2_CR84","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1038\/s41380-019-0414-4","volume":"25","author":"J Savitz","year":"2020","unstructured":"Savitz J (2020) The kynurenine pathway: a finger in every pie. Mol Psychiatry 25:131\u2013147","journal-title":"Mol Psychiatry"},{"key":"2_CR85","doi-asserted-by":"crossref","unstructured":"Setoyama D, Kato TA, Hashimoto R, Kunugi H, Hattori K, Hayakawa K, Sato-Kasai M, Shimokawa N, Kaneko S, Yoshida S et al (2016) Plasma metabolites predict severity of depression and suicidal ideation in psychiatric patients-a multicenter pilot analysis. PLoS One 11","DOI":"10.1371\/journal.pone.0165267"},{"key":"2_CR86","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.jad.2020.09.118","volume":"279","author":"D Setoyama","year":"2021","unstructured":"Setoyama D, Yoshino A, Takamura M, Okada G, Iwata M, Tsunetomi K, Ohgidani M, Kuwano N, Yoshimoto J, Okamoto Y et al (2021) Personality classification enhances blood metabolome analysis and biotyping for major depressive disorders: two-species investigation. J Affect Disord 279:20\u201330","journal-title":"J Affect Disord"},{"key":"2_CR87","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1002\/j.2051-5545.2008.tb00174.x","volume":"7","author":"E Simonsen","year":"2008","unstructured":"Simonsen E, Ronningstam E, Millon T (2008) A synopsis of the WPA educational program on personality disorders. World Psychiatry 7:119\u2013125","journal-title":"World Psychiatry"},{"key":"2_CR88","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.jad.2005.03.014","volume":"87","author":"DJ Smith","year":"2005","unstructured":"Smith DJ, Duffy L, Stewart ME, Muir WJ, Blackwood DHR (2005) High harm avoidance and low self-directedness in euthymic young adults with recurrent, early-onset depression. J Affect Disord 87:83\u201389","journal-title":"J Affect Disord"},{"key":"2_CR89","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1186\/s12888-020-02546-8","volume":"20","author":"A Steffen","year":"2020","unstructured":"Steffen A, N\u00fcbel J, Jacobi F, B\u00e4tzing J, Holstiege J (2020) Mental and somatic comorbidity of depression: a comprehensive cross-sectional analysis of 202 diagnosis groups using German nationwide ambulatory claims data. BMC Psychiatry 20:142","journal-title":"BMC Psychiatry"},{"key":"2_CR90","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41398-025-03371-x","volume":"15","author":"L Steinholtz","year":"2025","unstructured":"Steinholtz L, Bod\u00e9n R, Wall A, Lubberink M, F\u00e4llmar D, Persson J (2025) Alterations in gamma-aminobutyric acid and glutamate neurotransmission linked to intermittent theta-burst stimulation in depression: a sham-controlled study. Transl Psychiatry 15:1\u201310","journal-title":"Transl Psychiatry"},{"key":"2_CR91","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.1016\/j.bbi.2011.05.002","volume":"25","author":"ME Sublette","year":"2011","unstructured":"Sublette ME, Galfalvy HC, Fuchs D, Lapidus M, Grunebaum MF, Oquendo MA, John Mann J, Postolache TT (2011) Plasma kynurenine levels are elevated in suicide attempters with major depressive disorder. Brain Behav Immun 25:1272\u20131278","journal-title":"Brain Behav Immun"},{"key":"2_CR92","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1176\/appi.ajp.2017.17030283","volume":"175","author":"PF Sullivan","year":"2018","unstructured":"Sullivan PF, Agrawal A, Bulik CM, Andreassen OA, B\u00f8rglum AD, Breen G, Cichon S, Edenberg HJ, Faraone SV, Gelernter J et al (2018) Psychiatric genomics: an update and an agenda. Am J Psychiatry 175:15\u201327","journal-title":"Am J Psychiatry"},{"key":"2_CR93","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1016\/j.bbi.2020.01.011","volume":"87","author":"Y Sun","year":"2020","unstructured":"Sun Y, Drevets W, Turecki G, Li QS (2020) The relationship between plasma serotonin and kynurenine pathway metabolite levels and the treatment response to escitalopram and desvenlafaxine. Brain Behav Immun 87:404\u2013412","journal-title":"Brain Behav Immun"},{"key":"2_CR94","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0063756","volume":"8","author":"M Takahashi","year":"2013","unstructured":"Takahashi M, Shirayama Y, Muneoka K, Suzuki M, Sato K, Hashimoto K (2013) Personality traits as risk factors for treatment-resistant depression. Yoshikawa T, editor. PLoS ONE 8:e63756","journal-title":"PLoS ONE"},{"key":"2_CR95","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1111\/pcn.13475","volume":"76","author":"M Tateno","year":"2022","unstructured":"Tateno M, Kato TA (2022) Personality traits of female vocational school students in Japan with smartphone addiction with comorbid modern-type depression traits. Psychiatry Clin Neurosci 76:675\u2013676","journal-title":"Psychiatry Clin Neurosci"},{"key":"2_CR96","doi-asserted-by":"publisher","first-page":"g1253","DOI":"10.1136\/bmj.g1253","volume":"348","author":"BD Thombs","year":"2014","unstructured":"Thombs BD, Ziegelstein RC (2014) Does depression screening improve depression outcomes in primary care? BMJ 348:g1253\u2013g1253","journal-title":"BMJ"},{"key":"2_CR97","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n1661","volume":"374","author":"BD Thombs","year":"2021","unstructured":"Thombs BD, Markham S, Rice DB, Ziegelstein RC (2021) Does depression screening in primary care improve mental health outcomes? BMJ 374:n1661","journal-title":"BMJ"},{"key":"2_CR98","doi-asserted-by":"publisher","first-page":"3874","DOI":"10.1038\/s41380-023-02180-2","volume":"28","author":"A van der Spek","year":"2023","unstructured":"van der Spek A, Stewart ID, K\u00fchnel B, Pietzner M, Alshehri T, Gau\u00df F, Hysi PG, MahmoudianDehkordi S, Heinken A, Luik AI et al (2023) Circulating metabolites modulated by diet are associated with depression. Mol Psychiatry 28:3874\u20133887","journal-title":"Mol Psychiatry"},{"key":"2_CR99","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1038\/nrd3793","volume":"12","author":"L V\u00e9csei","year":"2013","unstructured":"V\u00e9csei L, Szal\u00e1rdy L, F\u00fcl\u00f6p F, Toldi J (2013) Kynurenines in the CNS: recent advances and new questions. Nat Rev Drug Discov 12:64\u201382","journal-title":"Nat Rev Drug Discov"},{"key":"2_CR100","first-page":"149","volume":"6","author":"JC Wakefield","year":"2007","unstructured":"Wakefield JC (2007) The concept of mental disorder: diagnostic implications of the harmful dysfunction analysis. World Psychiatry 6:149\u2013156","journal-title":"World Psychiatry"},{"key":"2_CR101","doi-asserted-by":"publisher","first-page":"1819","DOI":"10.1152\/physrev.00035.2018","volume":"99","author":"DS Wishart","year":"2019","unstructured":"Wishart DS (2019) Metabolomics for investigating physiological and pathophysiological processes. Physiol Rev 99:1819\u20131875","journal-title":"Physiol Rev"},{"key":"2_CR102","doi-asserted-by":"publisher","first-page":"4879","DOI":"10.1007\/s00216-015-8565-x","volume":"407","author":"P Yin","year":"2015","unstructured":"Yin P, Lehmann R, Xu G (2015) Effects of pre-analytical processes on blood samples used in metabolomics studies. Anal Bioanal Chem 407:4879\u20134892","journal-title":"Anal Bioanal Chem"},{"key":"2_CR103","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1038\/nm.3804","volume":"21","author":"YH Youm","year":"2015","unstructured":"Youm YH, Nguyen KY, Grant RW, Goldberg EL, Bodogai M, Kim D, D\u2019Agostino D, Planavsky N, Lupfer C, Kanneganti TD et al (2015) The ketone metabolite \u03b2-hydroxybutyrate blocks NLRP3 inflammasome-mediated inflammatory disease. Nat Med 21:263\u2013269","journal-title":"Nat Med"},{"key":"2_CR104","doi-asserted-by":"publisher","first-page":"3207","DOI":"10.1113\/jphysiol.2009.168757","volume":"587","author":"HX Zhang","year":"2009","unstructured":"Zhang HX, Hyrc K, Thio LL (2009) The glycine transport inhibitor sarcosine is an NMDA receptor co-agonist that differs from glycine. J Physiol 587:3207\u20133220","journal-title":"J Physiol"}],"container-title":["Advances in Experimental Medicine and Biology","Understanding Depression"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-981-95-6872-7_2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,26]],"date-time":"2026-04-26T22:19:30Z","timestamp":1777241970000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-981-95-6872-7_2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"ISBN":["9789819568710","9789819568727"],"references-count":104,"URL":"https:\/\/doi.org\/10.1007\/978-981-95-6872-7_2","relation":{},"ISSN":["0065-2598","2214-8019"],"issn-type":[{"value":"0065-2598","type":"print"},{"value":"2214-8019","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026]]},"assertion":[{"value":"1 April 2026","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The author(s) has no competing interests to declare that are relevant to the content of this manuscript.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}},{"value":"The author(s) declares that this manuscript does not include primary research with human participants.The author(s) declares that this manuscript does not include primary studies involving animals.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}}]}}